Staphylococcus aureus is a major human pathogen that causes a wide range of clinical
infections. It is a leading cause of bacteremia and infective endocarditis as well as …

Small colony variants (SCVs) were first described more than 100 years ago for
Staphylococcus aureus and various coagulase-negative staphylococci. Two decades ago …

The 2013 Infection Prevention and Control (IP&C) Guideline for Cystic Fibrosis (CF) was
commissioned by the CF Foundation as an update of the 2003 Infection Control Guideline …

The airways of patients with cystic fibrosis are colonized with diverse bacterial communities
that change dynamically during pediatric years and early adulthood. Staphylococcus aureus …

The airways of cystic fibrosis (CF) patients have thick mucus, which fosters chronic,
polymicrobial infections. Pseudomonas aeruginosa and Staphylococcus aureus are two of …

Rationale: Staphylococcus aureus and Pseudomonas aeruginosa often infect the airways in
cystic fibrosis (CF). Because registry studies show higher prevalence of P. aeruginosa …

Antimicrobial resistance is a significant threat to the treatment of infectious disease. Multiple
mechanisms of resistance to different classes of antibiotics have been identified and well …

Recent elucidation of the richness and complexity of the microbiome in patients with cystic
fibrosis (CF) has invigorated new discussions of the role of microbial infection in CF beyond …

Pseudomonas aeruginosa is a major pathogen in the lungs of cystic fibrosis (CF) patients.
However, it is now recognised that a diverse microbial community exists in the airways …

Recent studies of human respiratory secretions using culture-independent techniques have
found a surprisingly diverse array of microbes. Interactions among these community …